ANDA 204855, held by Actavis Labs Fl Inc. Lacosamide.
As of Nov 14, 2026, ANDA 204855 (Lacosamide), held by Actavis Labs Fl Inc, was first approved by FDA on Jan 5, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 5, 2023 | Original application | Approved |
| Lacosamide50MG · tablet;oral | Lacosamide | Discontinued |
| Lacosamide100MG · tablet;oral | Lacosamide | Discontinued |
| Lacosamide150MG · tablet;oral | Lacosamide | Discontinued |
| Lacosamide200MG · tablet;oral | Lacosamide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
